From GWAS hits to novel treatment targets
- Universität zu Lübeck
- Jeanette Erdmann
The project aims to systematically explore the human genome in cardiovascular disease, as well as to study the functional consequences of genomic variations in human cell and animal models. We wish to enhance diagnostic and therapeutic options particularly in the context of atherosclerosis and myocardial infarction. We systematically explored genome-wide association as well as genome-wide sequencing data and contributed to the identification of most currently known alleles affecting risk of the disease. Transgenic animal models (mice), also based on these newly identified genes, are about to further refine the mechanistic understanding of these processes. We aim to utilize these resources for the benefit of patients in terms of improved risk prediction and individualized medical treatment.
- myocardial infarction, coronary artery disease, genetics, GWAS, animal models, SNPs, NGS
- genetics of cardiovascular diseases
- € 1.841.521,35